Director/PDMR Shareholding

Xaar

02/10/2025 08:50

RNS Number : 8107B

Xaar PLC

02 October 2025

 

2 October 2025

Xaar plc

Notification of Transactions of Directors and PDMRs

Xaar plc (the "Company") announces that the Director/Person Discharging Managerial Responsibilities ("PDMR") listed below has traded in the Company's ordinary 10 pence shares ("Shares") as follows:

Name of Director/ PDMR
Date of Transaction
Nature of Transaction
Share Price (£)
Number of Shares/Share Options
Mr Ben Stocks
(Non-Executive Director)
1 October 2025
Purchase of Shares by Mrs Sara Stocks (wife)
£1.285
16,114

 

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation is appended below and gives further details on the transactions described above. 

This notification is made in accordance with DTR 3.1.4 R(1).

 

Enquiries:

Xaar plc
+44 (0)1223 423 663
Julia Crane,
Company Secretary
investor.relations@xaar.com

 

 

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mr Ben Stocks
2
Reason for the notification
a)
Position/status
Chairman and Non-Executive Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Xaar plc
b)
LEI
213800MXEC3KAOBBPO57
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary shares of 10 pence each
Identification code
GB0001570810
b)
Nature of the transaction
Purchase of Shares by Mrs Sara Stocks (wife of Mr Stocks)
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.285
16,114
d)
Aggregated information
- Aggregated volume
16,114
- Price
£20,706.49
e)
Date of the transaction
1 October 2025
f)
Place of the transaction
London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFIFVDIDLFIIE